Announcements Trials
Browse Landscape

Status

Recruiting 16Completed 5Active not recruiting 4Available 2Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

Sarcoma 1NET 1Endocrine 1CNS 1

Conditions

Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Pancreatic Neoplasms 6Sarcoma 5Prostatic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Recurrence 4Ovarian Neoplasms 4Neuroblastoma 4Multiple Myeloma 4Leukemia, Myeloid, Acute 4Breast Neoplasms 4Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Primary Myelofibrosis 2Osteosarcoma 2Non-Muscle Invasive Bladder Neoplasms 2Neuroectodermal Tumors, Primitive 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Insulinoma 2Hypoglycemia 2

Interventions

Eflornithine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Available × Neuroectodermal Tumors, Primitive × 1 year × Clear all
NCT03581240 2026-02-20

An Intermediate Expanded Use Trial of DFMO

Milton S. Hershey Medical Center

Available
CNS

Typical Teratoid Rhabdoid Tumor, Medulloblastoma, Neuroblastoma, Neuroectodermal Tumors, Primitive

NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Rezolute

Available
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡